nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolcapone—CYP2C9—Bexarotene—hematologic cancer	0.0905	0.191	CbGbCtD
Tolcapone—CYP2C9—Idarubicin—hematologic cancer	0.075	0.159	CbGbCtD
Tolcapone—CYP2C9—Bortezomib—hematologic cancer	0.0554	0.117	CbGbCtD
Tolcapone—CYP2C9—Thalidomide—hematologic cancer	0.0483	0.102	CbGbCtD
Tolcapone—CYP2C9—Teniposide—hematologic cancer	0.0461	0.0975	CbGbCtD
Tolcapone—CYP2C9—Ifosfamide—hematologic cancer	0.0425	0.09	CbGbCtD
Tolcapone—CYP2C9—Imatinib—hematologic cancer	0.0406	0.0859	CbGbCtD
Tolcapone—CYP2C9—Nilotinib—hematologic cancer	0.0369	0.0781	CbGbCtD
Tolcapone—CYP2C9—Cisplatin—hematologic cancer	0.0207	0.0438	CbGbCtD
Tolcapone—CYP2C9—Dexamethasone—hematologic cancer	0.0167	0.0353	CbGbCtD
Tolcapone—Niclosamide—STAT3—hematologic cancer	0.00551	0.814	CrCbGaD
Tolcapone—COMT—Biogenic Amine Synthesis—HDC—hematologic cancer	0.004	0.125	CbGpPWpGaD
Tolcapone—COMT—Neurotransmitter Clearance In The Synaptic Cleft—SLC22A1—hematologic cancer	0.00331	0.104	CbGpPWpGaD
Tolcapone—COMT—Methylation—MTR—hematologic cancer	0.00247	0.0772	CbGpPWpGaD
Tolcapone—COMT—Estrogen metabolism—UGT1A1—hematologic cancer	0.00178	0.0556	CbGpPWpGaD
Tolcapone—COMT—Dopamine metabolism—NQO1—hematologic cancer	0.00158	0.0495	CbGpPWpGaD
Tolcapone—Tolmetin—MPO—hematologic cancer	0.00126	0.186	CrCbGaD
Tolcapone—COMT—Estrogen metabolism—NQO1—hematologic cancer	0.00122	0.0381	CbGpPWpGaD
Tolcapone—COMT—Estrogen metabolism—GSTM1—hematologic cancer	0.000935	0.0292	CbGpPWpGaD
Tolcapone—COMT—Phase II conjugation—SLC35B2—hematologic cancer	0.000826	0.0258	CbGpPWpGaD
Tolcapone—COMT—hematopoietic system—hematologic cancer	0.000699	0.183	CbGeAlD
Tolcapone—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—hematologic cancer	0.000556	0.0174	CbGpPWpGaD
Tolcapone—COMT—Phase II conjugation—GSTO1—hematologic cancer	0.000532	0.0166	CbGpPWpGaD
Tolcapone—COMT—gonad—hematologic cancer	0.000532	0.139	CbGeAlD
Tolcapone—COMT—Phase II conjugation—UGT1A1—hematologic cancer	0.0005	0.0156	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—SLC35B2—hematologic cancer	0.000483	0.0151	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—EPHX1—hematologic cancer	0.000476	0.0149	CbGpPWpGaD
Tolcapone—COMT—blood—hematologic cancer	0.000463	0.121	CbGeAlD
Tolcapone—COMT—bone marrow—hematologic cancer	0.000448	0.117	CbGeAlD
Tolcapone—COMT—Phase II conjugation—MTR—hematologic cancer	0.000434	0.0135	CbGpPWpGaD
Tolcapone—COMT—Phase II conjugation—GSTT1—hematologic cancer	0.000413	0.0129	CbGpPWpGaD
Tolcapone—COMT—lung—hematologic cancer	0.000406	0.106	CbGeAlD
Tolcapone—COMT—testis—hematologic cancer	0.000383	0.1	CbGeAlD
Tolcapone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—hematologic cancer	0.00037	0.0116	CbGpPWpGaD
Tolcapone—CYP2C9—hematopoietic system—hematologic cancer	0.000368	0.0962	CbGeAlD
Tolcapone—COMT—Biological oxidations—GSTO1—hematologic cancer	0.000311	0.00972	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—GSTO1—hematologic cancer	0.000307	0.00959	CbGpPWpGaD
Tolcapone—CYP2C9—Constitutive Androstane Receptor Pathway—ABCC3—hematologic cancer	0.000307	0.00959	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—UGT1A1—hematologic cancer	0.000293	0.00914	CbGpPWpGaD
Tolcapone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—hematologic cancer	0.000292	0.00913	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—UGT1A1—hematologic cancer	0.000289	0.00902	CbGpPWpGaD
Tolcapone—CYP2C9—Constitutive Androstane Receptor Pathway—UGT1A1—hematologic cancer	0.000289	0.00901	CbGpPWpGaD
Tolcapone—COMT—Phase II conjugation—GSTP1—hematologic cancer	0.000286	0.00893	CbGpPWpGaD
Tolcapone—COMT—lymph node—hematologic cancer	0.000278	0.0727	CbGeAlD
Tolcapone—COMT—Phase II conjugation—GSTM1—hematologic cancer	0.000263	0.00821	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—MTR—hematologic cancer	0.000254	0.00793	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—SLC22A1—hematologic cancer	0.000252	0.00788	CbGpPWpGaD
Tolcapone—CYP2C9—blood—hematologic cancer	0.000243	0.0637	CbGeAlD
Tolcapone—COMT—Biological oxidations—GSTT1—hematologic cancer	0.000241	0.00754	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—ADCY7—hematologic cancer	0.000231	0.00722	CbGpPWpGaD
Tolcapone—CYP2C9—Constitutive Androstane Receptor Pathway—SMC1A—hematologic cancer	0.000225	0.00704	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—CAMK2D—hematologic cancer	0.000206	0.00643	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—SLC22A1—hematologic cancer	0.000193	0.00604	CbGpPWpGaD
Tolcapone—CYP2C9—Arachidonic acid metabolism—ALOX5—hematologic cancer	0.000191	0.00598	CbGpPWpGaD
Tolcapone—CYP2C9—Constitutive Androstane Receptor Pathway—HSP90AA1—hematologic cancer	0.000186	0.00581	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—ADCY7—hematologic cancer	0.000177	0.00553	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—GSTP1—hematologic cancer	0.000167	0.00523	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—GSTP1—hematologic cancer	0.000165	0.00515	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—CAMK2D—hematologic cancer	0.000158	0.00492	CbGpPWpGaD
Tolcapone—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—hematologic cancer	0.000156	0.00488	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—GSTM1—hematologic cancer	0.000154	0.0048	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—GSTM1—hematologic cancer	0.000152	0.00474	CbGpPWpGaD
Tolcapone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—hematologic cancer	0.000149	0.00465	CbGpPWpGaD
Tolcapone—CYP2C9—Constitutive Androstane Receptor Pathway—FOXO1—hematologic cancer	0.000148	0.00461	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—PRKCG—hematologic cancer	0.00013	0.00406	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PHYH—hematologic cancer	0.000128	0.004	CbGpPWpGaD
Tolcapone—COMT—Metabolism—FTCD—hematologic cancer	0.000128	0.004	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GMPS—hematologic cancer	0.000128	0.004	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—SLC35B2—hematologic cancer	0.000124	0.00387	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—EPHX1—hematologic cancer	0.000122	0.00382	CbGpPWpGaD
Tolcapone—COMT—Metabolism—SMPD3—hematologic cancer	0.000117	0.00366	CbGpPWpGaD
Tolcapone—COMT—Metabolism—B3GAT1—hematologic cancer	0.000102	0.0032	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ASNS—hematologic cancer	0.000102	0.0032	CbGpPWpGaD
Tolcapone—COMT—Metabolism—DCK—hematologic cancer	0.000102	0.0032	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—PRKCG—hematologic cancer	9.97e-05	0.00311	CbGpPWpGaD
Tolcapone—COMT—Metabolism—HDC—hematologic cancer	9.72e-05	0.00303	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—CREB1—hematologic cancer	9.63e-05	0.00301	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—BRAF—hematologic cancer	9.51e-05	0.00297	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CDA—hematologic cancer	8.89e-05	0.00278	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PC—hematologic cancer	8.55e-05	0.00267	CbGpPWpGaD
Tolcapone—COMT—Metabolism—SLC35B2—hematologic cancer	8.26e-05	0.00258	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GBA—hematologic cancer	8.26e-05	0.00258	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—GSTO1—hematologic cancer	7.99e-05	0.0025	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—MDM2—hematologic cancer	7.97e-05	0.00249	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—GSTO1—hematologic cancer	7.88e-05	0.00246	CbGpPWpGaD
Tolcapone—COMT—Metabolism—MTAP—hematologic cancer	7.56e-05	0.00236	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—UGT1A1—hematologic cancer	7.51e-05	0.00235	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—UGT1A1—hematologic cancer	7.41e-05	0.00231	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PHYH—hematologic cancer	7.39e-05	0.00231	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—CREB1—hematologic cancer	7.38e-05	0.00231	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—BRAF—hematologic cancer	7.29e-05	0.00228	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—SMPD3—hematologic cancer	6.76e-05	0.00211	CbGpPWpGaD
Tolcapone—COMT—Metabolism—FHL2—hematologic cancer	6.73e-05	0.0021	CbGpPWpGaD
Tolcapone—COMT—Metabolism—AGRN—hematologic cancer	6.6e-05	0.00206	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—MTR—hematologic cancer	6.52e-05	0.00204	CbGpPWpGaD
Tolcapone—COMT—Metabolism—IDH2—hematologic cancer	6.26e-05	0.00196	CbGpPWpGaD
Tolcapone—COMT—Metabolism—HMMR—hematologic cancer	6.26e-05	0.00196	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—GSTT1—hematologic cancer	6.2e-05	0.00194	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—MDM2—hematologic cancer	6.11e-05	0.00191	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ARNTL—hematologic cancer	5.89e-05	0.00184	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ACP5—hematologic cancer	5.73e-05	0.00179	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CA9—hematologic cancer	5.73e-05	0.00179	CbGpPWpGaD
Tolcapone—COMT—Metabolism—NCOR2—hematologic cancer	5.65e-05	0.00177	CbGpPWpGaD
Tolcapone—COMT—Metabolism—IDH1—hematologic cancer	5.38e-05	0.00168	CbGpPWpGaD
Tolcapone—COMT—Metabolism—TXN—hematologic cancer	5.32e-05	0.00166	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ABCC3—hematologic cancer	5.32e-05	0.00166	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GSTO1—hematologic cancer	5.32e-05	0.00166	CbGpPWpGaD
Tolcapone—COMT—Metabolism—SPHK1—hematologic cancer	5.21e-05	0.00163	CbGpPWpGaD
Tolcapone—COMT—Metabolism—UGT1A1—hematologic cancer	5.01e-05	0.00156	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CRABP1—hematologic cancer	4.87e-05	0.00152	CbGpPWpGaD
Tolcapone—COMT—Metabolism—SLC22A1—hematologic cancer	4.87e-05	0.00152	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	4.76e-05	0.00149	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ALOX5—hematologic cancer	4.75e-05	0.00148	CbGpPWpGaD
Tolcapone—COMT—Metabolism—NUP98—hematologic cancer	4.6e-05	0.00144	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ADCY7—hematologic cancer	4.46e-05	0.00139	CbGpPWpGaD
Tolcapone—COMT—Metabolism—NCOA3—hematologic cancer	4.46e-05	0.00139	CbGpPWpGaD
Tolcapone—COMT—Metabolism—NUP214—hematologic cancer	4.43e-05	0.00138	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—HRAS—hematologic cancer	4.37e-05	0.00137	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ABCG2—hematologic cancer	4.34e-05	0.00136	CbGpPWpGaD
Tolcapone—COMT—Metabolism—MTR—hematologic cancer	4.34e-05	0.00136	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—GSTP1—hematologic cancer	4.3e-05	0.00134	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ENO2—hematologic cancer	4.26e-05	0.00133	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—GSTP1—hematologic cancer	4.24e-05	0.00132	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GSTT1—hematologic cancer	4.13e-05	0.00129	CbGpPWpGaD
Tolcapone—COMT—Metabolism—SDC1—hematologic cancer	4.03e-05	0.00126	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—GSTM1—hematologic cancer	3.95e-05	0.00123	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—GSTM1—hematologic cancer	3.89e-05	0.00122	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	3.88e-05	0.00121	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CD44—hematologic cancer	3.43e-05	0.00107	CbGpPWpGaD
Tolcapone—COMT—Metabolism—NQO1—hematologic cancer	3.43e-05	0.00107	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	3.39e-05	0.00106	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—HRAS—hematologic cancer	3.35e-05	0.00105	CbGpPWpGaD
Tolcapone—Tachycardia—Prednisone—hematologic cancer	3.33e-05	6.87e-05	CcSEcCtD
Tolcapone—Alopecia—Epirubicin—hematologic cancer	3.32e-05	6.85e-05	CcSEcCtD
Tolcapone—Skin disorder—Prednisone—hematologic cancer	3.31e-05	6.84e-05	CcSEcCtD
Tolcapone—Nausea—Gemcitabine—hematologic cancer	3.31e-05	6.83e-05	CcSEcCtD
Tolcapone—Vomiting—Cisplatin—hematologic cancer	3.3e-05	6.82e-05	CcSEcCtD
Tolcapone—Hyperhidrosis—Prednisone—hematologic cancer	3.3e-05	6.81e-05	CcSEcCtD
Tolcapone—Vision blurred—Methotrexate—hematologic cancer	3.29e-05	6.79e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—PHYH—hematologic cancer	3.29e-05	0.00103	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GMPS—hematologic cancer	3.29e-05	0.00103	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—FTCD—hematologic cancer	3.29e-05	0.00103	CbGpPWpGaD
Tolcapone—Mental disorder—Epirubicin—hematologic cancer	3.29e-05	6.79e-05	CcSEcCtD
Tolcapone—Erythema multiforme—Doxorubicin—hematologic cancer	3.29e-05	6.78e-05	CcSEcCtD
Tolcapone—Rash—Cisplatin—hematologic cancer	3.28e-05	6.76e-05	CcSEcCtD
Tolcapone—Dermatitis—Cisplatin—hematologic cancer	3.27e-05	6.75e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	3.26e-05	0.00102	CbGpPWpGaD
Tolcapone—Diarrhoea—Etoposide—hematologic cancer	3.26e-05	6.72e-05	CcSEcCtD
Tolcapone—Anorexia—Prednisone—hematologic cancer	3.25e-05	6.71e-05	CcSEcCtD
Tolcapone—COMT—Metabolism—CYCS—hematologic cancer	3.25e-05	0.00101	CbGpPWpGaD
Tolcapone—Ill-defined disorder—Methotrexate—hematologic cancer	3.24e-05	6.69e-05	CcSEcCtD
Tolcapone—Tinnitus—Doxorubicin—hematologic cancer	3.24e-05	6.69e-05	CcSEcCtD
Tolcapone—Anaemia—Methotrexate—hematologic cancer	3.23e-05	6.66e-05	CcSEcCtD
Tolcapone—Feeling abnormal—Betamethasone—hematologic cancer	3.23e-05	6.66e-05	CcSEcCtD
Tolcapone—Feeling abnormal—Dexamethasone—hematologic cancer	3.23e-05	6.66e-05	CcSEcCtD
Tolcapone—COMT—Metabolism—HSP90AA1—hematologic cancer	3.23e-05	0.00101	CbGpPWpGaD
Tolcapone—Flatulence—Epirubicin—hematologic cancer	3.22e-05	6.65e-05	CcSEcCtD
Tolcapone—Tension—Epirubicin—hematologic cancer	3.21e-05	6.62e-05	CcSEcCtD
Tolcapone—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.2e-05	6.61e-05	CcSEcCtD
Tolcapone—Gastrointestinal pain—Betamethasone—hematologic cancer	3.2e-05	6.61e-05	CcSEcCtD
Tolcapone—Dysgeusia—Epirubicin—hematologic cancer	3.2e-05	6.61e-05	CcSEcCtD
Tolcapone—Hypersensitivity—Triamcinolone—hematologic cancer	3.18e-05	6.56e-05	CcSEcCtD
Tolcapone—Nervousness—Epirubicin—hematologic cancer	3.18e-05	6.55e-05	CcSEcCtD
Tolcapone—Angiopathy—Doxorubicin—hematologic cancer	3.15e-05	6.51e-05	CcSEcCtD
Tolcapone—Malaise—Methotrexate—hematologic cancer	3.15e-05	6.5e-05	CcSEcCtD
Tolcapone—Dizziness—Etoposide—hematologic cancer	3.15e-05	6.5e-05	CcSEcCtD
Tolcapone—Muscle spasms—Epirubicin—hematologic cancer	3.14e-05	6.49e-05	CcSEcCtD
Tolcapone—Vertigo—Methotrexate—hematologic cancer	3.14e-05	6.48e-05	CcSEcCtD
Tolcapone—Mediastinal disorder—Doxorubicin—hematologic cancer	3.13e-05	6.46e-05	CcSEcCtD
Tolcapone—Chills—Doxorubicin—hematologic cancer	3.12e-05	6.43e-05	CcSEcCtD
Tolcapone—Urticaria—Betamethasone—hematologic cancer	3.11e-05	6.42e-05	CcSEcCtD
Tolcapone—Urticaria—Dexamethasone—hematologic cancer	3.11e-05	6.42e-05	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.11e-05	6.41e-05	CcSEcCtD
Tolcapone—Dizziness—Prednisolone—hematologic cancer	3.11e-05	6.41e-05	CcSEcCtD
Tolcapone—Arrhythmia—Doxorubicin—hematologic cancer	3.1e-05	6.41e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	3.1e-05	0.000969	CbGpPWpGaD
Tolcapone—Asthenia—Triamcinolone—hematologic cancer	3.1e-05	6.39e-05	CcSEcCtD
Tolcapone—Body temperature increased—Dexamethasone—hematologic cancer	3.1e-05	6.39e-05	CcSEcCtD
Tolcapone—Abdominal pain—Dexamethasone—hematologic cancer	3.1e-05	6.39e-05	CcSEcCtD
Tolcapone—Abdominal pain—Betamethasone—hematologic cancer	3.1e-05	6.39e-05	CcSEcCtD
Tolcapone—Body temperature increased—Betamethasone—hematologic cancer	3.1e-05	6.39e-05	CcSEcCtD
Tolcapone—Nausea—Cisplatin—hematologic cancer	3.09e-05	6.37e-05	CcSEcCtD
Tolcapone—Vision blurred—Epirubicin—hematologic cancer	3.08e-05	6.36e-05	CcSEcCtD
Tolcapone—Alopecia—Doxorubicin—hematologic cancer	3.07e-05	6.34e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	3.07e-05	0.000959	CbGpPWpGaD
Tolcapone—Paraesthesia—Prednisone—hematologic cancer	3.06e-05	6.32e-05	CcSEcCtD
Tolcapone—Pruritus—Triamcinolone—hematologic cancer	3.05e-05	6.3e-05	CcSEcCtD
Tolcapone—Cough—Methotrexate—hematologic cancer	3.05e-05	6.29e-05	CcSEcCtD
Tolcapone—Mental disorder—Doxorubicin—hematologic cancer	3.04e-05	6.28e-05	CcSEcCtD
Tolcapone—Ill-defined disorder—Epirubicin—hematologic cancer	3.03e-05	6.26e-05	CcSEcCtD
Tolcapone—Vomiting—Etoposide—hematologic cancer	3.03e-05	6.25e-05	CcSEcCtD
Tolcapone—Anaemia—Epirubicin—hematologic cancer	3.02e-05	6.24e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—SMPD3—hematologic cancer	3.01e-05	0.00094	CbGpPWpGaD
Tolcapone—Agitation—Epirubicin—hematologic cancer	3e-05	6.2e-05	CcSEcCtD
Tolcapone—Dyspepsia—Prednisone—hematologic cancer	3e-05	6.2e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	3e-05	0.000938	CbGpPWpGaD
Tolcapone—Rash—Etoposide—hematologic cancer	3e-05	6.19e-05	CcSEcCtD
Tolcapone—Dermatitis—Etoposide—hematologic cancer	3e-05	6.19e-05	CcSEcCtD
Tolcapone—Headache—Etoposide—hematologic cancer	2.98e-05	6.15e-05	CcSEcCtD
Tolcapone—Flatulence—Doxorubicin—hematologic cancer	2.98e-05	6.15e-05	CcSEcCtD
Tolcapone—Chest pain—Methotrexate—hematologic cancer	2.97e-05	6.14e-05	CcSEcCtD
Tolcapone—Arthralgia—Methotrexate—hematologic cancer	2.97e-05	6.14e-05	CcSEcCtD
Tolcapone—Myalgia—Methotrexate—hematologic cancer	2.97e-05	6.14e-05	CcSEcCtD
Tolcapone—Tension—Doxorubicin—hematologic cancer	2.97e-05	6.13e-05	CcSEcCtD
Tolcapone—Decreased appetite—Prednisone—hematologic cancer	2.97e-05	6.12e-05	CcSEcCtD
Tolcapone—Dysgeusia—Doxorubicin—hematologic cancer	2.96e-05	6.11e-05	CcSEcCtD
Tolcapone—Rash—Prednisolone—hematologic cancer	2.96e-05	6.11e-05	CcSEcCtD
Tolcapone—Dermatitis—Prednisolone—hematologic cancer	2.96e-05	6.1e-05	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.95e-05	6.09e-05	CcSEcCtD
Tolcapone—Malaise—Epirubicin—hematologic cancer	2.95e-05	6.08e-05	CcSEcCtD
Tolcapone—Fatigue—Prednisone—hematologic cancer	2.94e-05	6.07e-05	CcSEcCtD
Tolcapone—Headache—Prednisolone—hematologic cancer	2.94e-05	6.07e-05	CcSEcCtD
Tolcapone—Discomfort—Methotrexate—hematologic cancer	2.94e-05	6.06e-05	CcSEcCtD
Tolcapone—Nervousness—Doxorubicin—hematologic cancer	2.94e-05	6.06e-05	CcSEcCtD
Tolcapone—Vertigo—Epirubicin—hematologic cancer	2.94e-05	6.06e-05	CcSEcCtD
Tolcapone—Syncope—Epirubicin—hematologic cancer	2.93e-05	6.05e-05	CcSEcCtD
Tolcapone—Constipation—Prednisone—hematologic cancer	2.92e-05	6.02e-05	CcSEcCtD
Tolcapone—Muscle spasms—Doxorubicin—hematologic cancer	2.91e-05	6e-05	CcSEcCtD
Tolcapone—Palpitations—Epirubicin—hematologic cancer	2.89e-05	5.96e-05	CcSEcCtD
Tolcapone—Confusional state—Methotrexate—hematologic cancer	2.88e-05	5.93e-05	CcSEcCtD
Tolcapone—Loss of consciousness—Epirubicin—hematologic cancer	2.87e-05	5.93e-05	CcSEcCtD
Tolcapone—COMT—Metabolism—GSTP1—hematologic cancer	2.86e-05	0.000894	CbGpPWpGaD
Tolcapone—Dizziness—Triamcinolone—hematologic cancer	2.86e-05	5.89e-05	CcSEcCtD
Tolcapone—Cough—Epirubicin—hematologic cancer	2.85e-05	5.89e-05	CcSEcCtD
Tolcapone—Vision blurred—Doxorubicin—hematologic cancer	2.85e-05	5.88e-05	CcSEcCtD
Tolcapone—Infection—Methotrexate—hematologic cancer	2.83e-05	5.84e-05	CcSEcCtD
Tolcapone—Nausea—Etoposide—hematologic cancer	2.83e-05	5.83e-05	CcSEcCtD
Tolcapone—Hypertension—Epirubicin—hematologic cancer	2.82e-05	5.82e-05	CcSEcCtD
Tolcapone—Feeling abnormal—Prednisone—hematologic cancer	2.81e-05	5.8e-05	CcSEcCtD
Tolcapone—Asthenia—Dexamethasone—hematologic cancer	2.81e-05	5.8e-05	CcSEcCtD
Tolcapone—Asthenia—Betamethasone—hematologic cancer	2.81e-05	5.8e-05	CcSEcCtD
Tolcapone—Ill-defined disorder—Doxorubicin—hematologic cancer	2.81e-05	5.79e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	2.81e-05	0.000877	CbGpPWpGaD
Tolcapone—Nervous system disorder—Methotrexate—hematologic cancer	2.8e-05	5.77e-05	CcSEcCtD
Tolcapone—Anaemia—Doxorubicin—hematologic cancer	2.8e-05	5.77e-05	CcSEcCtD
Tolcapone—Thrombocytopenia—Methotrexate—hematologic cancer	2.79e-05	5.76e-05	CcSEcCtD
Tolcapone—Gastrointestinal pain—Prednisone—hematologic cancer	2.79e-05	5.76e-05	CcSEcCtD
Tolcapone—Nausea—Prednisolone—hematologic cancer	2.79e-05	5.75e-05	CcSEcCtD
Tolcapone—Myalgia—Epirubicin—hematologic cancer	2.78e-05	5.74e-05	CcSEcCtD
Tolcapone—Arthralgia—Epirubicin—hematologic cancer	2.78e-05	5.74e-05	CcSEcCtD
Tolcapone—Chest pain—Epirubicin—hematologic cancer	2.78e-05	5.74e-05	CcSEcCtD
Tolcapone—Agitation—Doxorubicin—hematologic cancer	2.78e-05	5.74e-05	CcSEcCtD
Tolcapone—Anxiety—Epirubicin—hematologic cancer	2.77e-05	5.72e-05	CcSEcCtD
Tolcapone—Pruritus—Dexamethasone—hematologic cancer	2.77e-05	5.72e-05	CcSEcCtD
Tolcapone—Pruritus—Betamethasone—hematologic cancer	2.77e-05	5.72e-05	CcSEcCtD
Tolcapone—Skin disorder—Methotrexate—hematologic cancer	2.77e-05	5.71e-05	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.76e-05	5.7e-05	CcSEcCtD
Tolcapone—Hyperhidrosis—Methotrexate—hematologic cancer	2.76e-05	5.69e-05	CcSEcCtD
Tolcapone—Discomfort—Epirubicin—hematologic cancer	2.75e-05	5.67e-05	CcSEcCtD
Tolcapone—Vomiting—Triamcinolone—hematologic cancer	2.75e-05	5.66e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	2.74e-05	0.000854	CbGpPWpGaD
Tolcapone—Malaise—Doxorubicin—hematologic cancer	2.73e-05	5.63e-05	CcSEcCtD
Tolcapone—Rash—Triamcinolone—hematologic cancer	2.72e-05	5.62e-05	CcSEcCtD
Tolcapone—Dry mouth—Epirubicin—hematologic cancer	2.72e-05	5.62e-05	CcSEcCtD
Tolcapone—Dermatitis—Triamcinolone—hematologic cancer	2.72e-05	5.61e-05	CcSEcCtD
Tolcapone—Vertigo—Doxorubicin—hematologic cancer	2.72e-05	5.61e-05	CcSEcCtD
Tolcapone—Anorexia—Methotrexate—hematologic cancer	2.72e-05	5.61e-05	CcSEcCtD
Tolcapone—Syncope—Doxorubicin—hematologic cancer	2.71e-05	5.6e-05	CcSEcCtD
Tolcapone—Urticaria—Prednisone—hematologic cancer	2.71e-05	5.59e-05	CcSEcCtD
Tolcapone—COMT—Metabolism—ABCB1—hematologic cancer	2.71e-05	0.000846	CbGpPWpGaD
Tolcapone—Headache—Triamcinolone—hematologic cancer	2.71e-05	5.58e-05	CcSEcCtD
Tolcapone—Body temperature increased—Prednisone—hematologic cancer	2.7e-05	5.57e-05	CcSEcCtD
Tolcapone—Abdominal pain—Prednisone—hematologic cancer	2.7e-05	5.57e-05	CcSEcCtD
Tolcapone—Confusional state—Epirubicin—hematologic cancer	2.69e-05	5.55e-05	CcSEcCtD
Tolcapone—Diarrhoea—Dexamethasone—hematologic cancer	2.68e-05	5.53e-05	CcSEcCtD
Tolcapone—Diarrhoea—Betamethasone—hematologic cancer	2.68e-05	5.53e-05	CcSEcCtD
Tolcapone—Palpitations—Doxorubicin—hematologic cancer	2.67e-05	5.52e-05	CcSEcCtD
Tolcapone—Oedema—Epirubicin—hematologic cancer	2.67e-05	5.51e-05	CcSEcCtD
Tolcapone—Hypotension—Methotrexate—hematologic cancer	2.66e-05	5.5e-05	CcSEcCtD
Tolcapone—Loss of consciousness—Doxorubicin—hematologic cancer	2.66e-05	5.49e-05	CcSEcCtD
Tolcapone—Infection—Epirubicin—hematologic cancer	2.65e-05	5.47e-05	CcSEcCtD
Tolcapone—Cough—Doxorubicin—hematologic cancer	2.64e-05	5.45e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—ASNS—hematologic cancer	2.63e-05	0.000822	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—DCK—hematologic cancer	2.63e-05	0.000822	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—B3GAT1—hematologic cancer	2.63e-05	0.000822	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GSTM1—hematologic cancer	2.63e-05	0.000821	CbGpPWpGaD
Tolcapone—COMT—Metabolism—NCOR1—hematologic cancer	2.63e-05	0.000821	CbGpPWpGaD
Tolcapone—Shock—Epirubicin—hematologic cancer	2.63e-05	5.42e-05	CcSEcCtD
Tolcapone—Nervous system disorder—Epirubicin—hematologic cancer	2.62e-05	5.4e-05	CcSEcCtD
Tolcapone—Thrombocytopenia—Epirubicin—hematologic cancer	2.61e-05	5.39e-05	CcSEcCtD
Tolcapone—Hypertension—Doxorubicin—hematologic cancer	2.61e-05	5.39e-05	CcSEcCtD
Tolcapone—Tachycardia—Epirubicin—hematologic cancer	2.6e-05	5.37e-05	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.6e-05	5.36e-05	CcSEcCtD
Tolcapone—Skin disorder—Epirubicin—hematologic cancer	2.59e-05	5.35e-05	CcSEcCtD
Tolcapone—Dizziness—Dexamethasone—hematologic cancer	2.59e-05	5.35e-05	CcSEcCtD
Tolcapone—Dizziness—Betamethasone—hematologic cancer	2.59e-05	5.35e-05	CcSEcCtD
Tolcapone—Hyperhidrosis—Epirubicin—hematologic cancer	2.58e-05	5.32e-05	CcSEcCtD
Tolcapone—Arthralgia—Doxorubicin—hematologic cancer	2.58e-05	5.31e-05	CcSEcCtD
Tolcapone—Chest pain—Doxorubicin—hematologic cancer	2.58e-05	5.31e-05	CcSEcCtD
Tolcapone—Myalgia—Doxorubicin—hematologic cancer	2.58e-05	5.31e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	2.57e-05	0.000803	CbGpPWpGaD
Tolcapone—Anxiety—Doxorubicin—hematologic cancer	2.57e-05	5.3e-05	CcSEcCtD
Tolcapone—Nausea—Triamcinolone—hematologic cancer	2.56e-05	5.29e-05	CcSEcCtD
Tolcapone—Paraesthesia—Methotrexate—hematologic cancer	2.56e-05	5.28e-05	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.56e-05	5.28e-05	CcSEcCtD
Tolcapone—Discomfort—Doxorubicin—hematologic cancer	2.54e-05	5.25e-05	CcSEcCtD
Tolcapone—Anorexia—Epirubicin—hematologic cancer	2.54e-05	5.25e-05	CcSEcCtD
Tolcapone—Dyspnoea—Methotrexate—hematologic cancer	2.54e-05	5.25e-05	CcSEcCtD
Tolcapone—Somnolence—Methotrexate—hematologic cancer	2.54e-05	5.23e-05	CcSEcCtD
Tolcapone—Dry mouth—Doxorubicin—hematologic cancer	2.52e-05	5.2e-05	CcSEcCtD
Tolcapone—Hypersensitivity—Prednisone—hematologic cancer	2.51e-05	5.19e-05	CcSEcCtD
Tolcapone—Dyspepsia—Methotrexate—hematologic cancer	2.51e-05	5.18e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—HDC—hematologic cancer	2.49e-05	0.000779	CbGpPWpGaD
Tolcapone—Hypotension—Epirubicin—hematologic cancer	2.49e-05	5.14e-05	CcSEcCtD
Tolcapone—Vomiting—Dexamethasone—hematologic cancer	2.49e-05	5.14e-05	CcSEcCtD
Tolcapone—Vomiting—Betamethasone—hematologic cancer	2.49e-05	5.14e-05	CcSEcCtD
Tolcapone—Confusional state—Doxorubicin—hematologic cancer	2.49e-05	5.14e-05	CcSEcCtD
Tolcapone—Decreased appetite—Methotrexate—hematologic cancer	2.48e-05	5.11e-05	CcSEcCtD
Tolcapone—Rash—Betamethasone—hematologic cancer	2.47e-05	5.1e-05	CcSEcCtD
Tolcapone—Rash—Dexamethasone—hematologic cancer	2.47e-05	5.1e-05	CcSEcCtD
Tolcapone—Oedema—Doxorubicin—hematologic cancer	2.47e-05	5.09e-05	CcSEcCtD
Tolcapone—Dermatitis—Betamethasone—hematologic cancer	2.47e-05	5.09e-05	CcSEcCtD
Tolcapone—Dermatitis—Dexamethasone—hematologic cancer	2.47e-05	5.09e-05	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.46e-05	5.08e-05	CcSEcCtD
Tolcapone—Fatigue—Methotrexate—hematologic cancer	2.46e-05	5.07e-05	CcSEcCtD
Tolcapone—Headache—Dexamethasone—hematologic cancer	2.45e-05	5.06e-05	CcSEcCtD
Tolcapone—Headache—Betamethasone—hematologic cancer	2.45e-05	5.06e-05	CcSEcCtD
Tolcapone—Infection—Doxorubicin—hematologic cancer	2.45e-05	5.06e-05	CcSEcCtD
Tolcapone—Asthenia—Prednisone—hematologic cancer	2.45e-05	5.05e-05	CcSEcCtD
Tolcapone—Pain—Methotrexate—hematologic cancer	2.44e-05	5.03e-05	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.43e-05	5.02e-05	CcSEcCtD
Tolcapone—Shock—Doxorubicin—hematologic cancer	2.43e-05	5.01e-05	CcSEcCtD
Tolcapone—Nervous system disorder—Doxorubicin—hematologic cancer	2.42e-05	5e-05	CcSEcCtD
Tolcapone—Thrombocytopenia—Doxorubicin—hematologic cancer	2.42e-05	4.99e-05	CcSEcCtD
Tolcapone—Pruritus—Prednisone—hematologic cancer	2.41e-05	4.98e-05	CcSEcCtD
Tolcapone—Tachycardia—Doxorubicin—hematologic cancer	2.41e-05	4.97e-05	CcSEcCtD
Tolcapone—Skin disorder—Doxorubicin—hematologic cancer	2.4e-05	4.95e-05	CcSEcCtD
Tolcapone—Paraesthesia—Epirubicin—hematologic cancer	2.4e-05	4.94e-05	CcSEcCtD
Tolcapone—Hyperhidrosis—Doxorubicin—hematologic cancer	2.39e-05	4.92e-05	CcSEcCtD
Tolcapone—Dyspnoea—Epirubicin—hematologic cancer	2.38e-05	4.91e-05	CcSEcCtD
Tolcapone—Somnolence—Epirubicin—hematologic cancer	2.37e-05	4.89e-05	CcSEcCtD
Tolcapone—Anorexia—Doxorubicin—hematologic cancer	2.35e-05	4.86e-05	CcSEcCtD
Tolcapone—Feeling abnormal—Methotrexate—hematologic cancer	2.35e-05	4.85e-05	CcSEcCtD
Tolcapone—Dyspepsia—Epirubicin—hematologic cancer	2.35e-05	4.85e-05	CcSEcCtD
Tolcapone—Diarrhoea—Prednisone—hematologic cancer	2.33e-05	4.82e-05	CcSEcCtD
Tolcapone—Gastrointestinal pain—Methotrexate—hematologic cancer	2.33e-05	4.81e-05	CcSEcCtD
Tolcapone—Nausea—Dexamethasone—hematologic cancer	2.33e-05	4.8e-05	CcSEcCtD
Tolcapone—Nausea—Betamethasone—hematologic cancer	2.33e-05	4.8e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	2.33e-05	0.000727	CbGpPWpGaD
Tolcapone—COMT—Metabolism—MTHFR—hematologic cancer	2.32e-05	0.000726	CbGpPWpGaD
Tolcapone—Decreased appetite—Epirubicin—hematologic cancer	2.32e-05	4.79e-05	CcSEcCtD
Tolcapone—Hypotension—Doxorubicin—hematologic cancer	2.31e-05	4.76e-05	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.3e-05	4.75e-05	CcSEcCtD
Tolcapone—Fatigue—Epirubicin—hematologic cancer	2.3e-05	4.75e-05	CcSEcCtD
Tolcapone—Pain—Epirubicin—hematologic cancer	2.28e-05	4.71e-05	CcSEcCtD
Tolcapone—Constipation—Epirubicin—hematologic cancer	2.28e-05	4.71e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—CDA—hematologic cancer	2.28e-05	0.000713	CbGpPWpGaD
Tolcapone—Urticaria—Methotrexate—hematologic cancer	2.27e-05	4.67e-05	CcSEcCtD
Tolcapone—Dizziness—Prednisone—hematologic cancer	2.26e-05	4.66e-05	CcSEcCtD
Tolcapone—Body temperature increased—Methotrexate—hematologic cancer	2.25e-05	4.65e-05	CcSEcCtD
Tolcapone—Abdominal pain—Methotrexate—hematologic cancer	2.25e-05	4.65e-05	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.25e-05	4.64e-05	CcSEcCtD
Tolcapone—Paraesthesia—Doxorubicin—hematologic cancer	2.22e-05	4.57e-05	CcSEcCtD
Tolcapone—Dyspnoea—Doxorubicin—hematologic cancer	2.2e-05	4.54e-05	CcSEcCtD
Tolcapone—Feeling abnormal—Epirubicin—hematologic cancer	2.2e-05	4.54e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—PC—hematologic cancer	2.2e-05	0.000686	CbGpPWpGaD
Tolcapone—Somnolence—Doxorubicin—hematologic cancer	2.2e-05	4.53e-05	CcSEcCtD
Tolcapone—Gastrointestinal pain—Epirubicin—hematologic cancer	2.18e-05	4.5e-05	CcSEcCtD
Tolcapone—Dyspepsia—Doxorubicin—hematologic cancer	2.17e-05	4.48e-05	CcSEcCtD
Tolcapone—Vomiting—Prednisone—hematologic cancer	2.17e-05	4.48e-05	CcSEcCtD
Tolcapone—Rash—Prednisone—hematologic cancer	2.15e-05	4.44e-05	CcSEcCtD
Tolcapone—Dermatitis—Prednisone—hematologic cancer	2.15e-05	4.43e-05	CcSEcCtD
Tolcapone—Decreased appetite—Doxorubicin—hematologic cancer	2.15e-05	4.43e-05	CcSEcCtD
Tolcapone—Headache—Prednisone—hematologic cancer	2.14e-05	4.41e-05	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.13e-05	4.4e-05	CcSEcCtD
Tolcapone—Fatigue—Doxorubicin—hematologic cancer	2.13e-05	4.39e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—GBA—hematologic cancer	2.12e-05	0.000663	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—SLC35B2—hematologic cancer	2.12e-05	0.000663	CbGpPWpGaD
Tolcapone—Urticaria—Epirubicin—hematologic cancer	2.12e-05	4.37e-05	CcSEcCtD
Tolcapone—Constipation—Doxorubicin—hematologic cancer	2.11e-05	4.36e-05	CcSEcCtD
Tolcapone—Pain—Doxorubicin—hematologic cancer	2.11e-05	4.36e-05	CcSEcCtD
Tolcapone—Abdominal pain—Epirubicin—hematologic cancer	2.11e-05	4.35e-05	CcSEcCtD
Tolcapone—Body temperature increased—Epirubicin—hematologic cancer	2.11e-05	4.35e-05	CcSEcCtD
Tolcapone—Hypersensitivity—Methotrexate—hematologic cancer	2.1e-05	4.33e-05	CcSEcCtD
Tolcapone—Asthenia—Methotrexate—hematologic cancer	2.05e-05	4.22e-05	CcSEcCtD
Tolcapone—Feeling abnormal—Doxorubicin—hematologic cancer	2.03e-05	4.2e-05	CcSEcCtD
Tolcapone—Nausea—Prednisone—hematologic cancer	2.03e-05	4.18e-05	CcSEcCtD
Tolcapone—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.02e-05	4.17e-05	CcSEcCtD
Tolcapone—Pruritus—Methotrexate—hematologic cancer	2.02e-05	4.16e-05	CcSEcCtD
Tolcapone—Hypersensitivity—Epirubicin—hematologic cancer	1.97e-05	4.06e-05	CcSEcCtD
Tolcapone—Urticaria—Doxorubicin—hematologic cancer	1.96e-05	4.05e-05	CcSEcCtD
Tolcapone—COMT—Metabolism—PIK3CG—hematologic cancer	1.95e-05	0.00061	CbGpPWpGaD
Tolcapone—Body temperature increased—Doxorubicin—hematologic cancer	1.95e-05	4.03e-05	CcSEcCtD
Tolcapone—Abdominal pain—Doxorubicin—hematologic cancer	1.95e-05	4.03e-05	CcSEcCtD
Tolcapone—Diarrhoea—Methotrexate—hematologic cancer	1.95e-05	4.03e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—MTAP—hematologic cancer	1.94e-05	0.000606	CbGpPWpGaD
Tolcapone—Asthenia—Epirubicin—hematologic cancer	1.91e-05	3.95e-05	CcSEcCtD
Tolcapone—Pruritus—Epirubicin—hematologic cancer	1.89e-05	3.9e-05	CcSEcCtD
Tolcapone—Dizziness—Methotrexate—hematologic cancer	1.89e-05	3.89e-05	CcSEcCtD
Tolcapone—Diarrhoea—Epirubicin—hematologic cancer	1.83e-05	3.77e-05	CcSEcCtD
Tolcapone—Hypersensitivity—Doxorubicin—hematologic cancer	1.82e-05	3.75e-05	CcSEcCtD
Tolcapone—Vomiting—Methotrexate—hematologic cancer	1.81e-05	3.74e-05	CcSEcCtD
Tolcapone—COMT—Metabolism—CREBBP—hematologic cancer	1.81e-05	0.000565	CbGpPWpGaD
Tolcapone—Rash—Methotrexate—hematologic cancer	1.8e-05	3.71e-05	CcSEcCtD
Tolcapone—Dermatitis—Methotrexate—hematologic cancer	1.8e-05	3.71e-05	CcSEcCtD
Tolcapone—Headache—Methotrexate—hematologic cancer	1.79e-05	3.69e-05	CcSEcCtD
Tolcapone—Asthenia—Doxorubicin—hematologic cancer	1.77e-05	3.66e-05	CcSEcCtD
Tolcapone—Dizziness—Epirubicin—hematologic cancer	1.76e-05	3.64e-05	CcSEcCtD
Tolcapone—Pruritus—Doxorubicin—hematologic cancer	1.75e-05	3.6e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—FHL2—hematologic cancer	1.73e-05	0.00054	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PIK3CD—hematologic cancer	1.72e-05	0.000536	CbGpPWpGaD
Tolcapone—Vomiting—Epirubicin—hematologic cancer	1.7e-05	3.5e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—AGRN—hematologic cancer	1.7e-05	0.00053	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ALB—hematologic cancer	1.69e-05	0.000529	CbGpPWpGaD
Tolcapone—Nausea—Methotrexate—hematologic cancer	1.69e-05	3.49e-05	CcSEcCtD
Tolcapone—Diarrhoea—Doxorubicin—hematologic cancer	1.69e-05	3.49e-05	CcSEcCtD
Tolcapone—Rash—Epirubicin—hematologic cancer	1.68e-05	3.47e-05	CcSEcCtD
Tolcapone—Dermatitis—Epirubicin—hematologic cancer	1.68e-05	3.47e-05	CcSEcCtD
Tolcapone—Headache—Epirubicin—hematologic cancer	1.67e-05	3.45e-05	CcSEcCtD
Tolcapone—Dizziness—Doxorubicin—hematologic cancer	1.63e-05	3.37e-05	CcSEcCtD
Tolcapone—COMT—Metabolism—PIK3R1—hematologic cancer	1.62e-05	0.000506	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—HMMR—hematologic cancer	1.61e-05	0.000502	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—IDH2—hematologic cancer	1.61e-05	0.000502	CbGpPWpGaD
Tolcapone—Nausea—Epirubicin—hematologic cancer	1.59e-05	3.27e-05	CcSEcCtD
Tolcapone—Vomiting—Doxorubicin—hematologic cancer	1.57e-05	3.24e-05	CcSEcCtD
Tolcapone—Rash—Doxorubicin—hematologic cancer	1.56e-05	3.21e-05	CcSEcCtD
Tolcapone—Dermatitis—Doxorubicin—hematologic cancer	1.56e-05	3.21e-05	CcSEcCtD
Tolcapone—Headache—Doxorubicin—hematologic cancer	1.55e-05	3.19e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.52e-05	0.000473	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ARNTL—hematologic cancer	1.51e-05	0.000472	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PIK3CB—hematologic cancer	1.5e-05	0.000467	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CA9—hematologic cancer	1.47e-05	0.000459	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ACP5—hematologic cancer	1.47e-05	0.000459	CbGpPWpGaD
Tolcapone—Nausea—Doxorubicin—hematologic cancer	1.47e-05	3.03e-05	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—NCOR2—hematologic cancer	1.45e-05	0.000453	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—IDH1—hematologic cancer	1.38e-05	0.000432	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—TXN—hematologic cancer	1.37e-05	0.000427	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ABCC3—hematologic cancer	1.37e-05	0.000427	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTO1—hematologic cancer	1.37e-05	0.000427	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—SPHK1—hematologic cancer	1.34e-05	0.000418	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PTEN—hematologic cancer	1.29e-05	0.000404	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—UGT1A1—hematologic cancer	1.29e-05	0.000401	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—SLC22A1—hematologic cancer	1.25e-05	0.00039	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CRABP1—hematologic cancer	1.25e-05	0.00039	CbGpPWpGaD
Tolcapone—COMT—Metabolism—EP300—hematologic cancer	1.23e-05	0.000385	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ALOX5—hematologic cancer	1.22e-05	0.000381	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—NUP98—hematologic cancer	1.18e-05	0.000369	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ADCY7—hematologic cancer	1.15e-05	0.000358	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—NCOA3—hematologic cancer	1.15e-05	0.000358	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—NUP214—hematologic cancer	1.14e-05	0.000355	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.13e-05	0.000352	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—MTR—hematologic cancer	1.11e-05	0.000348	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ABCG2—hematologic cancer	1.11e-05	0.000348	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ENO2—hematologic cancer	1.09e-05	0.000341	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTT1—hematologic cancer	1.06e-05	0.000331	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.04e-05	0.000326	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—SDC1—hematologic cancer	1.04e-05	0.000324	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	9.89e-06	0.000309	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	9.77e-06	0.000305	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	9.34e-06	0.000292	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PIK3CA—hematologic cancer	9.12e-06	0.000285	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CD44—hematologic cancer	8.81e-06	0.000275	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—NQO1—hematologic cancer	8.81e-06	0.000275	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	8.62e-06	0.000269	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYCS—hematologic cancer	8.33e-06	0.00026	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	8.28e-06	0.000259	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	7.45e-06	0.000233	CbGpPWpGaD
Tolcapone—COMT—Metabolism—AKT1—hematologic cancer	7.45e-06	0.000233	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTP1—hematologic cancer	7.35e-06	0.000229	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	7.11e-06	0.000222	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ABCB1—hematologic cancer	6.95e-06	0.000217	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—NCOR1—hematologic cancer	6.75e-06	0.000211	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTM1—hematologic cancer	6.75e-06	0.000211	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—MTHFR—hematologic cancer	5.97e-06	0.000186	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.26e-06	0.000164	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PIK3CG—hematologic cancer	5.01e-06	0.000157	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CREBBP—hematologic cancer	4.65e-06	0.000145	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PIK3CD—hematologic cancer	4.41e-06	0.000138	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ALB—hematologic cancer	4.35e-06	0.000136	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PIK3R1—hematologic cancer	4.16e-06	0.00013	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PIK3CB—hematologic cancer	3.84e-06	0.00012	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PTEN—hematologic cancer	3.32e-06	0.000104	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—EP300—hematologic cancer	3.17e-06	9.89e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PIK3CA—hematologic cancer	2.34e-06	7.31e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—AKT1—hematologic cancer	1.91e-06	5.97e-05	CbGpPWpGaD
